OCA
CNTA
Octagon Capital Advisors’s Centessa Pharmaceuticals CNTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.5M | Sell |
1,030,000
-395,000
| -28% | -$5.19M | 2.97% | 17 |
|
|
2025
Q1 | $20.5M | Sell |
1,425,000
-568,052
| -29% | -$8.17M | 3.97% | 6 |
|
|
2024
Q4 | $33.4M | Sell |
1,993,052
-19,000
| -0.9% | -$318K | 5.49% | 4 |
|
|
2024
Q3 | $32.2M | Sell |
2,012,052
-333,023
| -14% | -$5.33M | 5% | 6 |
|
|
2024
Q2 | $21.2M | Buy |
2,345,075
+284,975
| +14% | +$2.57M | 3.33% | 9 |
|
|
2024
Q1 | $23.3M | Hold |
2,060,100
| – | – | 2.79% | 8 |
|
|
2023
Q4 | $16.4M | Buy |
2,060,100
+1,584,500
| +333% | +$12.6M | 2.62% | 11 |
|
|
2023
Q3 | $3.08M | Buy |
475,600
+63,672
| +15% | +$412K | 0.47% | 29 |
|
|
2023
Q2 | $2.55M | Buy |
411,928
+15,928
| +4% | +$98.6K | 0.35% | 32 |
|
|
2023
Q1 | $1.52M | Buy |
+396,000
| New | +$1.52M | 0.22% | 33 |
|